摘要
目的:探讨双黄连治疗小儿上呼吸道感染的临床效果。方法:对68例上呼吸道感染患儿随机分为治疗组35例,采用双黄连60 mg/(kg·d)一次静滴,疗程5 d;对照组33例采用利巴韦林10～15 mg/(kg·d)一次静滴,疗程5 d。两组其他抗生素及相应对症治疗相同。结果:治疗组平均退热天数、住院平均天数均较对照组短,P均<0.01。结论:双黄连治疗小儿上呼吸道感染效果比利巴韦林更好。
objective: To study the effects of Shuanghuanglian on acute upper respiratory infection of children. Methods: 68 cases of acute upper respiratory infection were divedid into two groups at randam: a treatment group of 35 cases treated with intravenous of Shuanghuanglian 60 mg/(kg · d) and a control group of 33 with intravenous drip of ribavirin 10 ~ 15 mg/(kg·d) . Besides, both groups received the some treatment of antibiotics, and other treatments. Results: After treating, the average days of fever allaying of the treating group is less than that of the control group (P<0. 01), the average day' at hospital is less too (P<0. 01) . Conclusion: Shuanghuanglian treatment of acute upper respiratory infection of chicdren has a better result than ribavirin one.
出处
《儿科药学杂志》
CAS
2003年第1期61-62,共2页
Journal of Pediatric Pharmacy
关键词
双黄连
小儿
上呼吸道感染
Shuanyhuanglian
Children
Acute upper respiratory infection
